Salem Investment Counselors Inc Abbott Laboratories Transaction History

Salem Investment Counselors Inc

  • $2.99 Billion
  • Q4 2024

A detailed history of Salem Investment Counselors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Salem Investment Counselors Inc holds 82,643 shares of ABT stock, worth $10.6 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
82,643
Previous 81,539 1.35%
Holding current value
$10.6 Million
Previous $9.3 Million 0.55%
% of portfolio
0.31%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
BUY
$111.93 - $119.39 $123,570 - $131,806
1,104 Added 1.35%
82,643 $9.35 Million
Q3 2024

Oct 15, 2024
SELL
$100.07 - $118.13 $51,936 - $61,309
-519 Reduced 0.63%
81,539 $9.3 Million
Q2 2024

Jul 11, 2024
SELL
$100.73 - $112.44 $102,744 - $114,688
-1,020 Reduced 1.23%
82,058 $8.53 Million
Q1 2024

Apr 11, 2024
SELL
$109.52 - $120.96 $5,585 - $6,168
-51 Reduced 0.06%
83,078 $9.44 Million
Q4 2023

Jan 16, 2024
SELL
$90.19 - $110.4 $36,526 - $44,712
-405 Reduced 0.48%
83,129 $9.15 Million
Q3 2023

Oct 04, 2023
BUY
$95.53 - $114.62 $1,432 - $1,719
15 Added 0.02%
83,534 $8.09 Million
Q2 2023

Jul 19, 2023
BUY
$100.78 - $112.29 $80,019 - $89,158
794 Added 0.96%
83,519 $9.11 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $816,045 - $960,534
8,425 Added 11.34%
82,725 $8.38 Million
Q4 2022

Feb 15, 2023
BUY
$95.06 - $111.52 $70,914 - $83,193
746 Added 1.01%
74,300 $8.16 Million
Q3 2022

Nov 09, 2022
SELL
$96.76 - $112.03 $30,866 - $35,737
-319 Reduced 0.43%
73,554 $7.12 Million
Q2 2022

Aug 17, 2022
BUY
$102.07 - $123.37 $203,323 - $245,753
1,992 Added 2.77%
73,873 $8.03 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $246,283 - $300,326
2,160 Added 3.1%
71,881 $8.51 Million
Q4 2021

Feb 15, 2022
BUY
$115.53 - $141.46 $108,713 - $133,113
941 Added 1.37%
69,721 $9.81 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $176,039 - $194,751
1,509 Added 2.24%
68,780 $8.13 Million
Q2 2021

Aug 17, 2021
BUY
$105.79 - $124.53 $215,811 - $254,041
2,040 Added 3.13%
67,271 $7.8 Million
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $21,114 - $24,876
-194 Reduced 0.3%
65,231 $7.82 Million
Q4 2020

Feb 17, 2021
BUY
$105.0 - $114.42 $217,245 - $236,734
2,069 Added 3.27%
65,425 $7.16 Million
Q3 2020

Nov 13, 2020
BUY
$91.64 - $111.29 $29,324 - $35,612
320 Added 0.51%
63,356 $6.9 Million
Q2 2020

Aug 13, 2020
BUY
$76.57 - $98.0 $30,092 - $38,514
393 Added 0.63%
63,036 $5.76 Million
Q1 2020

May 14, 2020
SELL
$62.82 - $91.86 $18,029 - $26,363
-287 Reduced 0.46%
62,643 $4.94 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $31,639 - $35,222
403 Added 0.64%
62,930 $5.47 Million
Q3 2019

Nov 13, 2019
SELL
$81.84 - $88.74 $47,058 - $51,025
-575 Reduced 0.91%
62,527 $5.23 Million
Q2 2019

Aug 14, 2019
SELL
$72.88 - $85.0 $1.24 Million - $1.44 Million
-16,962 Reduced 21.19%
63,102 $5.31 Million
Q1 2019

May 15, 2019
BUY
$66.22 - $80.06 $732,260 - $885,303
11,058 Added 16.02%
80,064 $5.87 Million
Q4 2018

Feb 15, 2019
SELL
$65.56 - $74.27 $724,962 - $821,277
-11,058 Reduced 13.81%
69,006 $4.99 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $15,384 - $18,560
-253 Reduced 0.32%
80,064 $5.87 Million
Q2 2018

Aug 15, 2018
SELL
$57.57 - $63.54 $382,667 - $422,350
-6,647 Reduced 7.64%
80,317 $4.9 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $84,405 - $95,430
-1,500 Reduced 1.7%
86,964 $5.12 Million
Q4 2017

Feb 16, 2018
SELL
$53.68 - $57.47 $362,393 - $387,979
-6,751 Reduced 7.09%
88,464 $5.05 Million
Q3 2017

Nov 16, 2017
BUY
$48.06 - $53.64 $4.58 Million - $5.11 Million
95,215
95,215 $5.1 Million

Others Institutions Holding ABT

# of Institutions
3,217
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email